ADDF Funding Opportunities

The Alzheimer's Drug Discovery Foundation (ADDF) provides funding to academic centers and biotechs from around the world that are advancing therapeutic and biomarker development for Alzheimer's and related dementias. We have dedicated our funding to several key areas:

• Translational research to develop new drugs and build preclinical evidence
• IND-enabling studies and early-stage clinical trials for novel and repurposed drugs
• Development and validation of plasma, CSF, neuroimaging and digital biomarkers
• Epidemiological studies and comparative effectiveness research

Upcoming 2021 deadlines
Must be received by 5:00 pm ET on the deadline date.

• Letter of Intent: February 5, 2021
• Invited Full Proposal: April 16, 2021

For more information, visit the ADDF Funding Opportunities page